INFIUSS HEALTH
Financials
Estimates*
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | <1m | <1m | <1m |
% growth | - | 500 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $30.0k | Grant | |
$500k | Grant | ||
N/A | Seed | ||
N/A | Angel | ||
| $50.0k | Seed | |
Total Funding | CAD791k |
Recent News about INFIUSS HEALTH
EditInfiuss Health operates Africa's first remote clinical research platform, designed to streamline the process of finding and recruiting participants for clinical studies. The platform serves pharmaceutical companies, academic researchers, and healthcare organizations by providing access to a vast pool of vetted and eligible participants across Africa. Operating in the clinical research market, Infiuss Health aims to decentralize trials and make them more inclusive by leveraging a direct-to-patient approach. The business model revolves around offering subscription-based access to its platform, which includes tools for participant screening, recruitment, and data collection. By significantly reducing the time and cost associated with participant recruitment, Infiuss Health generates revenue through subscription fees and potentially through partnerships with research institutions and sponsors.
Keywords: remote clinical research, participant recruitment, Africa, decentralized trials, healthcare, pharmaceutical, academic research, data collection, subscription-based, vetted participants.